by 
Automated cell counters are laboratory instruments used for counting and analyzing cells in biological samples. These systems perform rapid, accurate, and reproducible cell counts by flowing the cell suspension through a detection apparatus. They aid in analyzing cell viability, concentration, distribution and proliferation across various applications in research, drug discovery, and quality control processes. Common cell types counted include blood cells, yeast, plant, and mammalian cells. The global automated cell counters market has been gaining substantial momentum due to the increasing demand for high-throughput screening of cancer cells.
The global automated cell counters market is estimated to be valued at US$ 3.75 billion in 2023 and is expected to exhibit a CAGR of 7.0% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics
Increased Focus on Oncology Research to Drive Growth: Increased incidence of cancer across the globe has uplifted the focus on oncology research substantially. Automated cell counters facilitate rapid analysis of cancer and normal cell proliferation rates which aids in drug discovery and development process. Moreover, therapeutic development in cancer requires extensive screening of surface markers, morphology, and viability on cancer cell lines over time which is effectively done through automated cell counters. These factors are expected to boost the demand for automated cell counters in the forecast period.
Promising Future of Cancer Therapeutics to Create Opportunities: Advancements in fields like targeted therapy, immunotherapy, and stem cell therapy have demonstrated promising results against cancer. Continued research and clinical trials in these areas will require extensive cell analysis capabilities offered by automated cell counters. This presents lucrative business opportunities for manufacturers to develop novel solutions catering to evolving research needs.
Segment Analysis
The automated cell counters market is segmented into type, application, end user, and region. Based on type, the market is segmented into spectrometers and hematology analyzers. Among these, the hematology analyzers segment dominates the market, accounting for over 70% market share. The high accuracy and efficiency offered by hematology analyzers to count different types of cells such as RBCs, WBCs, and platelets drive the growth of this segment.
PEST Analysis
Political: Regulations regarding safety and accuracy of cell counting instruments are driving research and development activities to launch advanced products.
Economic: Rising prevalence of chronic diseases and growing expenditure on healthcare are fueling the demand for automated cell counters globally.
Social: Increasing awareness about cell counting applications in disease diagnosis and treatment is propelling the automated cell counters market growth.
Technological: Introduction of technologically advanced instruments with high throughput, accuracy, and usability is boosting the market. Automated cell counters integrated with artificial intelligence are gaining popularity.
Key Takeaways
The global automated cell counters market is estimated to be valued at US$ 3.75 billion in 2023 and is expected to exhibit a CAGR of 7.0% over the forecast period 2023 to 2030.
North America dominates the market currently owing to developed healthcare infrastructure and presence of key players in the region. The Asia Pacific region is projected to be the fastest growing market in the coming years due to increasing healthcare spending, rapid economic growth, and growing awareness about cell counting applications in the regions like China and India.
Key players operating in the automated cell counters market are Thermo Fisher Scientific, Danaher Corporation, Agilent Technologies, PerkinElmer Inc., Bio-Rad Laboratories, BD, Merck KGaA, Logos Biosystems, Corning Incorporated, and Tecan. Thermo Fisher Scientific and Danaher Corporation together hold over 40% of the global market share. These players are focusing on new product launches and expansions to strengthen their market presence.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemicals and materials, defense and aerospace, consumer goods, etc.
